Skip to Content
Merck
CN

New and experimental treatments of vitiligo and other hypomelanoses.

Dermatologic clinics (2007-07-31)
Torello Lotti, Francesca Prignano, Gionata Buggiani
ABSTRACT

This article deals with new and experimental treatments that can be used to treat various forms of depigmenting disorders. Ultraviolet B-focused therapies and new surgical approaches are analyzed in this article. These therapies were mainly or only developed to treat vitiligo, which is the most studied and probably the most challenging of all the hypomelanoses, but the results obtained in trials and clinical experiences about vitiligo sometimes can be referred to other depigmenting disorders.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4-(Benzyloxy)phenol, 98%